Amerigroup initiated at BofA/MerrillAGP initiated with a Buy rating and $42 price target. AGP is the HMO best positioned for health care reform, Bank of America/Merrill Lynch said.
Allegiant Travel upgraded at Jesup & LamontALGT was upgraded from Hold to Buy, Jesup & Lamont said. $56 price target. Investors are not giving the company credit for potentially stronger second-half results.
Allegheny Technologies upgraded at KeybancATI was upgraded from Hold to Buy, Keybanc said. $65 price target. Estimates also raised, as the company is cutting costs and is a late-cycle aerospace beneficiary.
Career Education upgraded at BarclaysCECO upgraded to Overweight from Equal Weight as it has superior earnings growth potential, Barclays said. Price target jumped to $43 from $29. 2010 and 2011 EPS estimates lifted to $2.78 and $3.41, respectively
Carpenter Technologies upgraded at KeybancCRS was upgraded from Hold to Buy, Keybanc said. $50 price target. Supply balance is converging well in aerospace engine components.
Crude Carriers initiated at BofA/MerrillCRU coverage initiated with a Buy rating and $22 price target. Valuable access at a discount, Bank of America/Merrill Lynch said. Crude Carriers is a crude tanker vessel owner with 5 vessels.
Discovery Communications rated new Buy at MKMDISCA was initiated with a Buy rating, MKM Partners said. $41 price target. Company should be able to generate higher advertising growth and continue to expand overseas.
Exelon downgraded at SoleilEXC was downgraded to Hold, Soleil Securities said. Company will be hurt by lower commodity and power prices. $40 price target.
Forest Laboratories downgraded at OppenheimerFRX was downgraded from Outperform to Perform, Oppenheimer said. There is a growing hole in the company's clinical pipeline.
Gilead Sciences estimates lowered at Morgan StanleyGILD estimates were cut through 2012, Morgan Stanley said. Company cut sales guidance, because of healthcare reform. Equal-weight rating and $48 price target.
Gilead Sciences downgraded at Piper JaffrayGILD downgraded at Piper Jaffray. Rating lowered to Neutral from Overweight. Price target lowered to $50 from $60. 2010 EPS estimates lowered to $3.62 from $3.82.
Mercadolibre initiated at Thomas WeiselMELI coverage initiated with an Overweight rating and $70 price target. MELI is one of the top-five secular growth stories on the internet due to the growth in users, usage and monetization, Thomas Weisel said.
Molina Healthcare initiated at BofA/MerrillMOH coverage initiated with a Buy rating and $35 price target, Bank of America/Merrill Lynch said. Stronger near-term outlook after disappointing 2009 results could trigger revaluation in share on evidence that profitability is rebounding.
Parker Hannifin upgraded at UBSPH was upgraded from Sell to Neutral, UBS said. $73 price target. Estimates also boosted, as the company is seeing better climate and industrial sales.
Parker Hannifin numbers boosted at GoldmanPH estimates were raised through 2012, Goldman Sachs said. Company is seeing higher sales across the board. Neutral rating and new $81 price target.
Transocean downgraded at Credit SuisseRIG downgraded to Neutral from Outperform on valuation and near-term earnings risk, Credit Suisse said. 2010 and 2011 EPS estimates held at $8.20 and $9.05. Maintain $94 price target.
RPM International upgraded at BofA/MerrillRPM upgraded to Buy from Neutral based on improvement in the company's consumer segment and eventual recpvery in industrial segment, Bank of America/Merrill Lynch said. Price target raised to $25 from $23.
Strayer Education downgraded at BarclaysSTRA downgraded to Equal Weight from Overweight on valuation, Barclays said. Price target increased to $272 from $240. 2010 and 2011 EPS estimates held at $9.47 and $11.34, respectively.
VMware upgraded at BofA/MerrillVMW upgraded to Neutral from Underperform following strong quarter and outlook, Bank of America/Merrill Lynch said. Price target jumped to $60 from $36.
VMWare upgraded at JMPVMW was upgraded from Market Perform to Outperform, JMP Securities said. $74 price target. Estimates also raised, as customers cotinue to spend on Computing as a Service.
Warner Chilcott initiated at BofA/MerrillWCRX coverage initiated at Bank of America/Merrill Lynch with a Buy rating and $34 price target. Timely product approvals, solid execution and deals could support multiple expansion.
AAPL price target surged to $300 from $260 after 2Q10 earnings blew past expectations, Bank of America/Merrill Lynch said. 2010 and 2011 EPS estimates improved to $13.19 and $14.15, respectively. Maintain Buy.
Apple estimates, target increased at Goldman
Shares of AAPL now seen reaching $270, according to Goldman Sachs. Estimates also upped, given better sales and operating leverage. Neutral rating.
Apple estimates, target increased at GoldmanShares of AAPL now seen reaching $270, according to Goldman Sachs. Estimates also upped, given better sales and operating leverage. Neutral rating.
Altera estimates, target upped at GoldmanALTR estimates were raised through 2012, Goldman Sachs said. Company is seeing higher sales and gross margins. Neutral rating and ne $24 price target.
Amylin Pharmaceuticals price target higher at Credit SuisseAMLN price target lifted to $30 from $28 as the likelihood of a favorable response by the FDA regarding Bydureon is high, Credit Suisse said. Reiterate Outperform rating.
Amphenol estimates, target boosted at UBSAPH estimates were increased through 2011, UBS said. Company is seeing higher demand across the board. Neutral rating and $52 price target.
Coach estimates, target boosted at GoldmanCOH estimates were increased through 2012, Goldman Sachs said. Company is seeing better sales and gross margins. Neutral rating and new $43 price target.
Cisco Systems target, estimates boosted at BarclaysCSCO price target increased to $31 from $28 on continued improvement in enterprise and healthy carrier markets, Barclays said. 2010 and 2011 EPS estimates lifted to $1.60 and $1.85, respectively. Overweight rating.
Delta Air Lines estimates raised at UBSDAL estimates were increased through 2011, UBS said. Company is cutting costs and should see higher sales. Buy rating and $17 price target.
Eaton estimates, target raised at GoldmanETN estimates were increased through 2012, Goldman Sachs said. Company boosted its guidance, because of higher realized margins. Neutral rating and new $88 price target.
Edwards Lifesciences numbers boosted at GoldmanShares of EW now seen reaching $120, according to Goldman Sachs. Estimates also increased, as the company is realizing higher margins. Buy rating.
Harley-Davidson estimates boosted at GoldmanHOG estimates were increased through 2012, Goldman Sachs said. Company is seeing higher motorcycle profits and improved credit costs. Sell rating and $30 price target.
Illinois Tool Works numbers upped at GoldmanShares of ITW now seen reaching $61, according to Goldman Sachs. Estimates also raised, as the company appears to be regaining sales momentum. Buy rating.
J.C. Penney estimates, target raised at GoldmanShares of JCP now seen reaching $38, according to Goldman Sachs. Estimates also increased, given higher expected same-store sales. Buy rating.
Jacobs Engineering numbers boosted at FBRShares of JEC now seen reaching $53, according to FBR Capital Markets. Estimates were also increased, to match the company's new guidance. Outperform rating.
Jefferies estimates lowered at GoldmanJEF estimates were reduced through 2012, Goldman Sachs said. Company will be hurt by a higher share count and is seeing softer trading revenue. Sell rating and $26 price target.
Johnson & Johnson estimates lowered at GoldmanJNJ estimates were cut through 2012, Goldman Sachs said. Company is being hurt by healthcare reform. Neutral rating and $65 price target.
Juniper Networks estimates upped at GoldmanJNPR estimates were raised through 2011, Goldman Sachs said. Accounting uncertainty has created a buying opportunity. Still, deferred revenues are growing and the company is seeing higher operating margins. Buy rating and $34 price target.
Eli Lilly estimates cut at Morgan StanleyLLY estimates were reduced through 2012, Morgan Stanley said. Company will be hurt by healthcare reform. Underweight rating and $34 price target.
Microsoft estimates tweaked at BarclaysMSFT 2010 and 2011 EPS estimates raised to $2.04 and $2.29, respectively. Consumer PC strength and improving IT spending trends, Barclays noted. Reiterate Equal Weight rating and $35 target.
News Corp. numbers raised at Morgan StanleyNWSA target was boosted to $18, Morgan Stanley said. Estimates were also increased, given Avatar sales and newspaper revenue growth. Equal-weight rating.
Omnicomm estimates, target raised at Morgan StanleyShares of OMC now seen reaching $51, Morgan Stanley said. Company is seeing better organic sales growth. Overweight rating.
Paccar estimates, target boosted at GoldmanShares of PCAR now seen reaching $47, Goldman Sachs said. Estimates also upped, because of a continued truck recovery. Neutral rating.
Panera Bread numbers increased at GoldmanPNRA estimates were upped through 2012, Goldman Sachs said. Company is realizing better sales and margins. Neutral rating and new $85 price target.
Synovus Financial estimates lowered at FBRSNV estimates were cut through 2011, FBR Capital Markets said. Company will likely need to raise capital soon. Underperform rating and $2.50 price target.
Steel Dynamics estimates cut at UBSSTLD estimates were lowered through 2011, UBS said. Company is seeing a more muted recovery. Buy rating and $23 price target.
Seagate Technology estimates upped at UBSSTX estimates were raised through 2011, UBS said. Company will likely resume its share buyback. Buy rating and $31 price target.
Total System Services numbers boosted at GoldmanShares of TSS now seen reaching $14, Goldman Sachs said. Estimates also increased, as the company is benefitting from a better macro environment. Sell rating.
Tupperware estimates, target raised at GoldmanShares of TUP now seen reaching $60, according to Goldman Sachs. Estimates also increased, given strong sales momentum. Neutral rating.
Weatherford estimates lowered at GoldmanWFT estimates were reduced through 2012, Goldman Sachs said. Weaker international results are offsetting growth in North America. Neutral rating and $19 price target.
Wal-Mart price target boosted at Credit SuisseWMT price target improved to $58 from $53 as gross margins have driven earnings growth recently, Credit Suisse said. Maintain Neutral rating.
Wolverine World Wide numbers boosted at CitigroupShares of WWW now seen reaching $35, according to Citigroup. Estimates also increased, as the company's recent sales growth appears sustainable. Buy rating.
Xilinx estimates increased at UBSXLNX estimates were raised through 2011, UBS said. Company should see better demand in the industrial and communications markets. Buy rating and $32 price target.
Yahoo estimates, target increased at GoldmanYHOO estimates were boosted through 2012, Goldman Sachs said. Company is seeing a lower tax rate and expected to buy back more stock. Neutral rating and new $20 price target.
